Shenzhen Institute of Advanced Biomedical Robot Co.,Ltd., also known as Abrobo, was founded in June 2020. The company specializes in design, development and manufacturing of pan-vascular interventional robotic systems that promote the industrialization of interventional robotic technology. As a pioneer in the field of interventional robotic systems, Abrobo upholds user-centered product development principle. By January 2024, Abrobo has obtained more than 460 pieces of intellectual property involving both domestic and international invention patents.